Pharmacist's Letter Canada

Article: Explain That Full Benefit of Levothyroxine May Take 6 Months January 2015

Article: Suggest Saving Ezetimibe as an Add-On in High-Risk Patients January 2015

Commentary: Treatment of Hypothyroidism: When Levothyroxine Fails January 2015

Commentary: Ezetimibe’s Role in Cardiovascular Risk Reduction January 2015

PL Voices: How to Manage Patients Who Don’t Respond Well To Levothyroxine January 2015

PL Voices: Role of Ezetimibe (Zetia, etc) for Dyslipidemia January 2015

PL Voices: Role of New Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardioversion December 2014

Guideline: 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation December 2014

Article: Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion December 2014

PL Voices: Role of New Oral Anticoagulants for Treatment of Venous Thromboembolism November 2014

Commentary: Diclofenac: Cardiovascular Safety Information and Dose Change November 2014

Article: Suggest Xarelto Over Pradaxa for Treating VTE November 2014

Article: Recommend NOT Going Over 100 mg/day of Diclofenac Orally or Rectally November 2014

Guideline: 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery October 2014

PL Voices: Duration of Treatment of Dual Antiplatelet Therapy October 2014

Resources